Home › Translational Research Program

Translational Research Program

Investigators:

Jane Buckner, MD, Associate Member, Program Director, Associate Director BRI
Kris Kowdley, MD
James Lord, MD, PhD, Research Assistant Member
S. Alice Long, PhD, Research Assistant Member
Brad Stone, PhD, Research Assistant Member
Karen Cerosaletti, PhD, Research Assistant Member

Clinician Investigators at Virginia Mason Medical Center:

Mariko Kita, MD - Multiple Sclerosis
Anthony Gerbino, MD- Pulmonary Diseases
David Robinson, MD – Allergy Immunology

Laboratories:

Buckner Laboratory
Kowdley Laboratory
Lord Laboratory
Stone Laboratory

Core Facilities:

Array Core Laboratory
Clinical Core Laboratory
Genotyping Core Laboratory
Human Immunophenotyping Core Laboratory

The research emphasis of the BRI Translational Research Program is the area of immune mediated diseases. This includes the study of autoimmune and allergic diseases. The diseases that are being actively studied at this time include:

Type 1 Diabetes

Rheumatic Diseases with an emphasis on those diseases listed below:

Pulmonary Disease

  • Asthma
  • Scleroderma
  • Idiopathic Pulmonary Fibrosis
  • Sarcoidosis

Gastrointestinal Disease

  • Ulcerative Colitis
  • Crohn's Disease
  • Hepatology

Neurologic Disease

  • Multiple Sclerosis
  • ALS or Lou Gehrig's Disease

Allergy

The Translational Research Program includes a group of Clinical Coordinators who interface with research participants, a Clinical Core Laboratory which handles and track all samples obtained from individuals, then transfers samples to the research laboratories.

Translational Research Program Group

Jane Buckner, MD
Christine Chan
Ami Charmley
Thien-Son Nguyen
Mark Bramlett
Rachel Rogers
Kate DeGraaff
Bert Park
Katherine Nickel
Amber Matheny
Jennifer Heaton
Kevin Criste